crossmark
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014 Helio S. Sader, Mariana Castanheira, Robert K. Flamm, Ronald N. Jones JMI Laboratories, North Liberty, Iowa, USA
A total of 7,272 unique patient clinical isolates were collected from 71 U.S. medical centers from patients with urinary tract infections in 2012 to 2014 and tested for susceptibility to ceftazidime-avibactam and comparators by broth microdilution methods. Ceftazidimeavibactam inhibited >99.9% of all Enterobacteriaceae at the susceptible breakpoint of
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014 Helio S. Sader, Mariana Castanheira, Robert K. Flamm, Ronald N. Jones JMI Laboratories, North Liberty, Iowa, USA
A total of 7,272 unique patient clinical isolates were collected from 71 U.S. medical centers from patients with urinary tract infections in 2012 to 2014 and tested for susceptibility to ceftazidime-avibactam and comparators by broth microdilution methods. Ceftazidimeavibactam inhibited >99.9% of all Enterobacteriaceae at the susceptible breakpoint of
